US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
ATE220327T1
(de)
*
|
1992-09-29 |
2002-07-15 |
Inhale Therapeutic Syst |
Pulmonale abgabe von aktiven fragmenten des parathormons
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
ES2218543T3
(es)
*
|
1994-03-07 |
2004-11-16 |
Nektar Therapeutics |
Procedimiento y preparacion para la administracion de insulina por via pulmonar.
|
AU696387B2
(en)
*
|
1994-05-18 |
1998-09-10 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions for the dry powder formulation of interferons
|
US6165976A
(en)
*
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
DK0806945T3
(da)
*
|
1994-12-22 |
2003-08-04 |
Astrazeneca Ab |
Terapeutisk præparat til inhalering, indeholdende parathyroideahormon, PTH
|
NZ298169A
(en)
|
1994-12-22 |
1999-09-29 |
Astra Ab |
Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US6309671B1
(en)
|
1995-04-14 |
2001-10-30 |
Inhale Therapeutic Systems |
Stable glassy state powder formulations
|
US6165463A
(en)
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US6019968A
(en)
*
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
US6315983B1
(en)
|
1996-01-24 |
2001-11-13 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Process for the production of powdered pulmonary surfactant preparations
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US6503480B1
(en)
*
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
EP1019031A4
(en)
|
1997-07-18 |
2003-02-05 |
Infimed Inc |
BIODEGRADABLE MACROMERS FOR THE REGULATED RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
TW581681B
(en)
|
1998-02-20 |
2004-04-01 |
Nektar Therapeutics |
Liquid crystal forms of cyclosporin
|
EP2311436A1
(en)
|
1998-04-27 |
2011-04-20 |
Altus Pharmaceuticals Inc. |
Stabilized protein crystals, formulations containing them and methods of making them
|
US6284282B1
(en)
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
AU3764199A
(en)
*
|
1998-04-29 |
1999-11-16 |
Genentech Inc. |
Spray dried formulations of igf-i
|
GB9810559D0
(en)
*
|
1998-05-15 |
1998-07-15 |
Bradford Particle Design Ltd |
Method and apparatus for particle formation
|
US6451349B1
(en)
|
1998-08-19 |
2002-09-17 |
Quadrant Healthcare (Uk) Limited |
Spray-drying process for the preparation of microparticles
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US20070212422A1
(en)
*
|
1999-11-10 |
2007-09-13 |
Manfred Keller |
Dry powder for inhalation
|
PT1165050E
(pt)
|
1999-04-05 |
2006-06-30 |
Mannkind Corp |
Processos para formacao de po fino
|
WO2000061178A1
(en)
*
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
EP1169053A1
(en)
|
1999-04-13 |
2002-01-09 |
Inhale Therapeutic Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
EP1185248B1
(en)
|
1999-06-09 |
2012-05-02 |
Robert E. Sievers |
Supercritical fluid-assisted nebulization and bubble drying
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
EP1196430B1
(en)
*
|
1999-06-29 |
2012-02-15 |
MannKind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
KR100667720B1
(ko)
*
|
1999-06-30 |
2007-01-15 |
넥타르 테라퓨틱스 |
건조 분말을 제조하기 위한 분무 건조 방법
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
ITMI991582A1
(it)
*
|
1999-07-16 |
2001-01-16 |
Chiesi Farma Spa |
Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6586008B1
(en)
*
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
JP2003507410A
(ja)
*
|
1999-08-25 |
2003-02-25 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
乾燥粉末製剤からの放出調節
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7252840B1
(en)
|
1999-08-25 |
2007-08-07 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles
|
AU775565B2
(en)
|
1999-10-29 |
2004-08-05 |
Novartis Ag |
Dry powder compositions having improved dispersivity
|
US7507687B2
(en)
*
|
2000-03-22 |
2009-03-24 |
Cabot Corporation |
Electrocatalyst powders, methods for producing powder and devices fabricated from same
|
MXPA02001323A
(es)
*
|
2000-05-10 |
2004-07-16 |
Alliance Pharma |
Microgranulos con base fosfolipida para la liberacion de farmaco.
|
US20040176391A1
(en)
*
|
2002-12-31 |
2004-09-09 |
Nektar Therapeutics |
Aerosolizable pharmaceutical formulation for fungal infection therapy
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
AU2001277230A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Inhale Therapeutic Systems, Inc. |
Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
|
EP1309312A2
(en)
*
|
2000-08-07 |
2003-05-14 |
Inhale Therapeutic Systems, Inc. |
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
|
CA2423469A1
(en)
*
|
2000-10-18 |
2002-04-25 |
Massachusetts Institute Of Technology |
Methods and products related to pulmonary delivery of polysaccharides
|
WO2002043580A2
(en)
|
2000-10-27 |
2002-06-06 |
Epic Therapeutics, Inc. |
Production of microspheres
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
ATE355849T1
(de)
*
|
2000-12-21 |
2007-03-15 |
Nektar Therapeutics |
Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US6887462B2
(en)
|
2001-04-09 |
2005-05-03 |
Chiron Corporation |
HSA-free formulations of interferon-beta
|
US6848197B2
(en)
|
2001-04-18 |
2005-02-01 |
Advanced Inhalation Research, Inc. |
Control of process humidity to produce large, porous particles
|
US20050054596A1
(en)
*
|
2001-11-30 |
2005-03-10 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20040198682A1
(en)
*
|
2001-11-30 |
2004-10-07 |
Mcswiggen James |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
|
US20050182009A1
(en)
*
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)
|
US20050148530A1
(en)
*
|
2002-02-20 |
2005-07-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20050176666A1
(en)
*
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)
|
US20050159382A1
(en)
*
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
|
US20050182007A1
(en)
*
|
2001-05-18 |
2005-08-18 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20050164968A1
(en)
*
|
2001-05-18 |
2005-07-28 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)
|
US20060241075A1
(en)
*
|
2001-05-18 |
2006-10-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of desmoglein gene expression using short interfering nucleic acid (siNA)
|
US20050014172A1
(en)
*
|
2002-02-20 |
2005-01-20 |
Ivan Richards |
RNA interference mediated inhibition of muscarinic cholinergic receptor gene expression using short interfering nucleic acid (siNA)
|
US20050288242A1
(en)
*
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)
|
US20050233997A1
(en)
*
|
2001-05-18 |
2005-10-20 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
|
US20050187174A1
(en)
*
|
2001-05-18 |
2005-08-25 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
|
US7517864B2
(en)
*
|
2001-05-18 |
2009-04-14 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20050256068A1
(en)
*
|
2001-05-18 |
2005-11-17 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
|
US20050159376A1
(en)
*
|
2002-02-20 |
2005-07-21 |
Slrna Therapeutics, Inc. |
RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
|
US20050267058A1
(en)
*
|
2001-05-18 |
2005-12-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
|
US20050159380A1
(en)
*
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)
|
US20050282188A1
(en)
*
|
2001-05-18 |
2005-12-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US9994853B2
(en)
|
2001-05-18 |
2018-06-12 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
US20050233344A1
(en)
*
|
2001-05-18 |
2005-10-20 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
|
US20050176664A1
(en)
*
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)
|
US20070042983A1
(en)
*
|
2001-05-18 |
2007-02-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20070270579A1
(en)
*
|
2001-05-18 |
2007-11-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20050222066A1
(en)
*
|
2001-05-18 |
2005-10-06 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20060019913A1
(en)
*
|
2001-05-18 |
2006-01-26 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibtion of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)
|
US20050287128A1
(en)
*
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
US20050143333A1
(en)
*
|
2001-05-18 |
2005-06-30 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
|
US20050227935A1
(en)
*
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
|
US20080161256A1
(en)
*
|
2001-05-18 |
2008-07-03 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)
|
US20050119212A1
(en)
*
|
2001-05-18 |
2005-06-02 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of FAS and FASL gene expression using short interfering nucleic acid (siNA)
|
US20050203040A1
(en)
*
|
2001-05-18 |
2005-09-15 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
|
NZ519403A
(en)
*
|
2001-06-21 |
2005-03-24 |
Pfizer Prod Inc |
Use of insulin in a medicament to reduce weight gain in a diabetic patient who is using exogenous insulin to control blood sugar levels
|
WO2003035051A2
(en)
*
|
2001-10-19 |
2003-05-01 |
Inhale Therapeutic Systems, Inc. |
The use of proton sequestering agents in drug formulations
|
WO2003035028A1
(en)
*
|
2001-10-19 |
2003-05-01 |
Nektar Therapeutics |
Modulating charge density to produce improvements in the characteristics of spray-dried proteins
|
WO2003037303A1
(en)
|
2001-11-01 |
2003-05-08 |
Nektar Therapeutics |
Spray drying methods and compositions thereof
|
PT1455755E
(pt)
*
|
2001-11-20 |
2013-06-18 |
Civitas Therapeutics Inc |
Composições particuladas melhoradas para distribuição pulmonar
|
US20030099601A1
(en)
*
|
2001-11-27 |
2003-05-29 |
Gordon Marc S. |
Inhalation lung surfactant therapy
|
US20070203333A1
(en)
*
|
2001-11-30 |
2007-08-30 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20040138163A1
(en)
*
|
2002-05-29 |
2004-07-15 |
Mcswiggen James |
RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US20050075304A1
(en)
*
|
2001-11-30 |
2005-04-07 |
Mcswiggen James |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
ATE508735T1
(de)
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
Pulmonale verabreichung von aminoglykosiden
|
US20050042632A1
(en)
*
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US20040014679A1
(en)
*
|
2002-02-20 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
|
US9181551B2
(en)
|
2002-02-20 |
2015-11-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
US20050137153A1
(en)
*
|
2002-02-20 |
2005-06-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA)
|
US9657294B2
(en)
|
2002-02-20 |
2017-05-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
US20040063912A1
(en)
*
|
2002-03-15 |
2004-04-01 |
The Brigham And Women's Hospital, Inc. |
Central airway administration for systemic delivery of therapeutics
|
CN100343393C
(zh)
*
|
2002-03-15 |
2007-10-17 |
布赖汉姆妇女医院 |
适合治疗剂全身性递送的中央气道给药
|
CA2478327A1
(en)
*
|
2002-03-20 |
2003-10-02 |
Advanced Inhalation Research, Inc. |
Hgh (human growth hormone) formulations for pulmonary administration
|
US7008644B2
(en)
*
|
2002-03-20 |
2006-03-07 |
Advanced Inhalation Research, Inc. |
Method and apparatus for producing dry particles
|
US20050163725A1
(en)
*
|
2002-03-20 |
2005-07-28 |
Blizzard Charles D. |
Method for administration of growth hormone via pulmonary delivery
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
AU2003221888B2
(en)
*
|
2002-04-11 |
2008-11-06 |
Medimmune, Llc |
Preservation of bioactive materials by spray drying
|
CA2483271A1
(en)
*
|
2002-04-25 |
2003-11-06 |
Momenta Pharmaceuticals, Inc. |
Methods and products for mucosal delivery
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
DE10234165B4
(de)
*
|
2002-07-26 |
2008-01-03 |
Advanced Micro Devices, Inc., Sunnyvale |
Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
|
CA2508592A1
(en)
*
|
2002-12-17 |
2004-07-15 |
Medimmune Vaccines, Inc. |
High pressure spray-dry of bioactive materials
|
EP1589901A4
(en)
|
2002-12-20 |
2006-08-09 |
Generipharm Inc |
INTRACUTANEOUS INJECTION
|
AU2003302329B2
(en)
*
|
2002-12-30 |
2010-01-07 |
Novartis Ag |
Prefilming atomizer
|
CA2511523C
(en)
*
|
2002-12-31 |
2013-10-15 |
Nektar Therapeutics |
Pharmaceutical formulation with an insoluble active agent for pulmonary administration
|
KR100500675B1
(ko)
*
|
2003-02-10 |
2005-07-11 |
주식회사 에이앤피사이언스 |
고유량 입자 분무장치
|
GB0304540D0
(en)
*
|
2003-02-27 |
2003-04-02 |
Elan Drug Delivery Ltd |
Particle formulation and its preparation
|
AU2004251623B2
(en)
*
|
2003-05-28 |
2010-03-18 |
Novartis Ag |
Spray drying of an alcoholic aqueous solution for the manufacture of a water-in-soluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
|
US20050014230A1
(en)
*
|
2003-07-16 |
2005-01-20 |
Ccl Holding Co., Ltd. |
Preparation of fully human antibodies
|
AU2004261190A1
(en)
*
|
2003-07-28 |
2005-02-10 |
Harvest Tec, Inc. |
Apparatus, method, and system for applying substances to pre-harvested or harvested forage, grain, and crops
|
US20050042179A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
|
US20050043247A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative
|
US20050042180A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder
|
US20050042178A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
CA2540699A1
(en)
*
|
2003-10-01 |
2005-04-14 |
Momenta Pharmaceuticals, Inc. |
Polysaccharides for pulmonary delivery of active agents
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US20050214224A1
(en)
*
|
2003-11-04 |
2005-09-29 |
Nektar Therapeutics |
Lipid formulations for spontaneous drug encapsulation
|
KR20050056799A
(ko)
*
|
2003-12-10 |
2005-06-16 |
엘지.필립스 엘시디 주식회사 |
액정 표시패널의 실 패턴 구조
|
EP1701714A2
(en)
|
2004-01-07 |
2006-09-20 |
Nektar Therapeutics |
Improved sustained release compositions for pulmonary administration of insulin
|
NZ548980A
(en)
*
|
2004-01-12 |
2009-10-30 |
Mannkind Corp |
Reducing serum proinsulin levels in type 2 diabetics
|
US20050186146A1
(en)
*
|
2004-02-12 |
2005-08-25 |
Nektar Therapeutics |
Interleukin-13 antagonist powders, spray-dried particles, and methods
|
PL1740154T3
(pl)
*
|
2004-03-12 |
2009-11-30 |
Biodel Inc |
Kompozycje insuliny o ulepszonym wchłanianiu
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
JP2007534693A
(ja)
*
|
2004-04-23 |
2007-11-29 |
サイデックス・インコーポレイテッド |
スルホアルキルエーテルシクロデキストリンを含有するdpi製剤
|
DE102004022926A1
(de)
*
|
2004-05-10 |
2005-12-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
DE102004022928A1
(de)
*
|
2004-05-10 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US10508277B2
(en)
|
2004-05-24 |
2019-12-17 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
US8513204B2
(en)
*
|
2004-06-21 |
2013-08-20 |
Novartis Ag |
Compositions comprising amphotericin B, mehods and systems
|
JP2008503586A
(ja)
*
|
2004-06-21 |
2008-02-07 |
ネクター セラピューティクス |
アンフォテリシンbを含む組成物、方法、およびシステム
|
CA2580313C
(en)
|
2004-07-19 |
2016-03-15 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
US20060024272A1
(en)
|
2004-07-29 |
2006-02-02 |
Large Scale Biology Corporation |
C-terminally truncated interferon
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
PL1791542T3
(pl)
*
|
2004-08-23 |
2015-11-30 |
Mannkind Corp |
Sole diketopiperazyny do dostarczania leków
|
SE0402345L
(sv)
*
|
2004-09-24 |
2006-03-25 |
Mederio Ag |
Uppmätt läkemedelsdos
|
US9149433B2
(en)
*
|
2004-11-30 |
2015-10-06 |
Basf Corporation |
Method for formation of micro-prilled polymers
|
EP1819639A4
(en)
*
|
2004-11-30 |
2012-05-02 |
Univ Tulane |
PROCESS FOR TREATING NEBULIZATION
|
US20060160871A1
(en)
*
|
2004-12-07 |
2006-07-20 |
Nektar Therapeutics |
Stable non-crystalline formulation comprising losartan
|
WO2006078841A1
(en)
*
|
2005-01-21 |
2006-07-27 |
President And Fellows Of Harvard College |
Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles
|
EP1866407A4
(en)
*
|
2005-03-22 |
2010-07-14 |
Regeron Inc |
DEVICE AND METHOD FOR SUBMICRONIZING PROTEINS USING SUPERCRITICAL LIQUIDS
|
JP5087539B2
(ja)
|
2005-05-18 |
2012-12-05 |
ネクター セラピューティックス |
気管支内治療のためのバルブ、デバイス、および方法
|
WO2007019554A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Momenta Pharmaceuticals, Inc. |
Polysaccharides for delivery of active agents
|
AU2006290870B2
(en)
|
2005-09-14 |
2013-02-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
JP5096363B2
(ja)
|
2005-12-16 |
2012-12-12 |
ネクター セラピューティックス |
Glp−1のポリマ複合体
|
WO2007102946A2
(en)
|
2006-01-23 |
2007-09-13 |
Amgen Inc. |
Crystalline polypeptides
|
CN101404980A
(zh)
|
2006-01-24 |
2009-04-08 |
耐百生物制药有限公司 |
大分子微球的制备技术
|
GB0602897D0
(en)
*
|
2006-02-13 |
2006-03-22 |
Jagotec Ag |
Improvements In Or Relating To Dry Powder Inhaler Devices
|
EP2497484A3
(en)
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
MX2008013165A
(es)
*
|
2006-04-12 |
2009-01-29 |
Biodel Inc |
Formulaciones de combinacion de insulina de accion rapida y accion larga.
|
US8681999B2
(en)
|
2006-10-23 |
2014-03-25 |
Starkey Laboratories, Inc. |
Entrainment avoidance with an auto regressive filter
|
GB0622818D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
GB0625303D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Jagotec Ag |
Improvements in and relating to metered dose inhalers
|
US7985058B2
(en)
*
|
2007-01-12 |
2011-07-26 |
Mark Gray |
Method and apparatus for making uniformly sized particles
|
EP2152304B1
(en)
*
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
EP2207890A4
(en)
|
2007-10-05 |
2010-12-15 |
Barofold Inc |
HIGH PRESSURE PROCESSING OF AGGREGATED INTERFERONS
|
US20100316625A1
(en)
*
|
2007-12-21 |
2010-12-16 |
Inspiration Biopharmaceuticals, Inc. |
Stabilized factor ix formulations containing trehalose
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
AU2009246217B2
(en)
*
|
2008-05-15 |
2013-01-10 |
Novartis Ag |
Pulmonary delivery of a fluoroquinolone
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
DK2570147T3
(da)
|
2008-06-13 |
2018-01-29 |
Mannkind Corp |
Tørpulverinhalator og system til lægemiddelindgivelse
|
KR101628410B1
(ko)
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
CA2737461A1
(en)
|
2008-09-19 |
2010-03-25 |
Tandem Diabetes Care, Inc. |
Solute concentration measurement device and related methods
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
US20100092526A1
(en)
*
|
2008-09-26 |
2010-04-15 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
CA2736907C
(en)
|
2008-10-03 |
2018-06-05 |
E.I. Du Pont De Nemours And Company |
Improved perhydrolases for enzymatic peracid generation
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
US9827205B2
(en)
*
|
2008-12-12 |
2017-11-28 |
Mallinckrodt Pharma Ip Trading D.A.C. |
Dry powder fibrin sealant
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
ES2531009T3
(es)
|
2008-12-29 |
2015-03-09 |
Mannkind Corp |
Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
|
AU2010217760B2
(en)
|
2009-02-27 |
2015-04-09 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
EP3552602A1
(en)
|
2009-03-18 |
2019-10-16 |
Incarda Therapeutics, Inc. |
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
US20120016011A1
(en)
|
2009-03-19 |
2012-01-19 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
EP2408915A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
CN102439151A
(zh)
|
2009-03-19 |
2012-05-02 |
默沙东公司 |
使用短干扰核酸(siNA)的RNA干扰介导的BTB和CNC同系物1,碱性亮氨酸拉链转录因子1(Bach1)基因表达的抑制
|
US20120035247A1
(en)
|
2009-03-19 |
2012-02-09 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
JP2012521764A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸(siNA)を用いた胸腺間質性リンパ球新生因子(TSLP)遺伝子発現のRNA干渉媒介性阻害
|
EP2411019A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
WO2010111468A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
WO2010111464A1
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
SG174581A1
(en)
|
2009-03-27 |
2011-10-28 |
Merck Sharp & Dohme |
RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US10011906B2
(en)
|
2009-03-31 |
2018-07-03 |
Beohringer Ingelheim International Gmbh |
Method for coating a surface of a component
|
CA2757500A1
(en)
|
2009-04-01 |
2010-10-07 |
Promedior, Inc. |
Pulmonary and nasal delivery of serum amyloid p
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
EP2440251A4
(en)
|
2009-06-09 |
2013-01-16 |
Defyrus Inc |
INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
|
US8734845B2
(en)
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
EP2459251B1
(en)
|
2009-07-30 |
2014-03-12 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
US8222012B2
(en)
|
2009-10-01 |
2012-07-17 |
E. I. Du Pont De Nemours And Company |
Perhydrolase for enzymatic peracid production
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
EP2496246B1
(en)
*
|
2009-11-03 |
2018-06-27 |
Grifols Therapeutics LLC |
Composition, method, and kit for alpha-1 proteinase inhibitor
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
JP5715640B2
(ja)
|
2009-11-25 |
2015-05-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
EP2504051B1
(en)
|
2009-11-25 |
2019-09-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
ES2622462T3
(es)
*
|
2009-12-03 |
2017-07-06 |
Purac Biochem Bv |
Polvo de cinamato de metal alcalino y procedimiento de preparación del mismo
|
CA2781896C
(en)
|
2009-12-09 |
2021-03-30 |
Nitto Denko Corporation |
Modulation of hsp47 expression
|
CN101816913B
(zh)
*
|
2010-05-20 |
2015-10-21 |
吴传斌 |
一种微球制造方法及制造设备
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EP2585151B1
(en)
|
2010-06-24 |
2018-04-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
BR112013006044B1
(pt)
|
2010-09-24 |
2022-03-29 |
University Of Florida Research Foundation, Inc |
Composição terapêutica para administração enteral compreendendo como aminoácidos livres, serina e valina, bem como embalagem contendo a dita composição
|
EP3766975A1
(en)
|
2010-10-29 |
2021-01-20 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
|
CA2823628A1
(en)
|
2011-01-05 |
2012-07-12 |
Hospira, Inc. |
Spray drying vancomycin
|
JP5893051B2
(ja)
*
|
2011-02-10 |
2016-03-23 |
クルセル ホランド ベー ヴェー |
交互空気圧膜式細胞分離システム
|
MX350838B
(es)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Composicion de sal.
|
US8708159B2
(en)
*
|
2011-02-16 |
2014-04-29 |
Oakwood Laboratories, Llc |
Manufacture of microspheres using a hydrocyclone
|
RU2603610C2
(ru)
|
2011-02-25 |
2016-11-27 |
Конинклейке Филипс Электроникс Н.В. |
Устройство для генерирования аэрозоля для распыления жидкости, и способ управления температурой распыляемой жидкости
|
CA2828002A1
(en)
|
2011-03-03 |
2012-09-07 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating lung disease and injury
|
CN105853348B
(zh)
|
2011-03-10 |
2019-08-30 |
Xeris药物公司 |
肠胃外注射用稳定溶液
|
EP3225235B1
(en)
|
2011-03-10 |
2020-12-16 |
Xeris Pharmaceuticals, Inc. |
Stable peptide formulations for parenteral injection
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
MY180552A
(en)
|
2011-04-01 |
2020-12-02 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
US9572774B2
(en)
|
2011-05-19 |
2017-02-21 |
Savara Inc. |
Dry powder vancomycin compositions and associated methods
|
EP2709646A4
(en)
*
|
2011-05-19 |
2015-05-13 |
Savara Inc |
DRY POWDER VANCOMYCIN COMPOSITIONS AND RELATED METHODS
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
US9011903B2
(en)
|
2011-06-08 |
2015-04-21 |
Nitto Denko Corporation |
Cationic lipids for therapeutic agent delivery formulations
|
PT2998289T
(pt)
|
2011-06-08 |
2019-09-19 |
Nitto Denko Corp |
Compostos para direcionar a distribuição de fármaco e melhorar a atividade de sirna
|
TWI658830B
(zh)
|
2011-06-08 |
2019-05-11 |
日東電工股份有限公司 |
Hsp47表現調控強化用類視色素脂質體
|
US10196637B2
(en)
|
2011-06-08 |
2019-02-05 |
Nitto Denko Corporation |
Retinoid-lipid drug carrier
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
EA037797B1
(ru)
|
2011-10-25 |
2021-05-21 |
Протена Байосайенсиз Лимитед |
Состав антитела, пригодный для профилактики и лечения амилоидоза, его варианты и способ его получения
|
KR102007057B1
(ko)
|
2011-10-31 |
2019-08-02 |
엑스에리스 파머수티클스, 인크. |
당뇨병 치료를 위한 제형물
|
WO2013067281A1
(en)
*
|
2011-11-04 |
2013-05-10 |
Battelle Memorial Institute |
Processes for producing protein microparticles
|
EP2601941A1
(en)
|
2011-12-06 |
2013-06-12 |
Ludwig-Maximilians-Universität München |
Beta-O/S/N fatty acid based compounds as antibacterial and antiprotozoal agents
|
MX2014007277A
(es)
|
2011-12-16 |
2014-07-28 |
Novartis Ag |
Aparato de aerosolizacion para administracion de farmaco independiente del perfil de inhalacion.
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
EP2833891B1
(en)
|
2012-04-05 |
2018-07-25 |
University of Florida Research Foundation, Inc. |
Compostion for treatment of cystic fibrosis and for induction of ion secretion
|
US8753643B1
(en)
|
2012-04-11 |
2014-06-17 |
Life-Science Innovations, Llc |
Spray dried compositions and methods of use
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
EP2836204B1
(en)
|
2012-04-13 |
2020-07-08 |
GlaxoSmithKline Intellectual Property Development Limited |
Aggregate particles
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US9555186B2
(en)
|
2012-06-05 |
2017-01-31 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
WO2014005103A2
(en)
|
2012-06-28 |
2014-01-03 |
Ansun Biopharma, Inc. |
Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture
|
CA2878457C
(en)
|
2012-07-12 |
2021-01-19 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
WO2014124096A1
(en)
|
2013-02-06 |
2014-08-14 |
Perosphere Inc. |
Stable glucagon formulations
|
CA2904046C
(en)
|
2013-03-11 |
2020-01-14 |
University Of Florida Research Foundation, Incorporated |
Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
JP2016518388A
(ja)
|
2013-04-30 |
2016-06-23 |
オティトピック インク. |
乾燥粉末配合および使用方法
|
WO2014207213A1
(en)
|
2013-06-28 |
2014-12-31 |
Medizinische Universität Innsbruck |
Novel inhibitors of protein kinase c epsilon signaling
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
WO2015018904A1
(en)
|
2013-08-09 |
2015-02-12 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
EP2835146B1
(en)
|
2013-08-09 |
2020-09-30 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
PL3107548T3
(pl)
|
2014-02-20 |
2022-10-31 |
Otitopic Inc. |
Suche formulacje w proszku do inhalacji
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
HUE055604T2
(hu)
|
2014-05-07 |
2021-12-28 |
Boehringer Ingelheim Int |
Porlasztó
|
BR112016023932B1
(pt)
|
2014-05-07 |
2022-11-29 |
Boehringer Ingelheim International Gmbh |
Nebulizador
|
JP6580070B2
(ja)
|
2014-05-07 |
2019-09-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
容器、ネブライザ、及び使用
|
EP2947460A1
(en)
|
2014-05-22 |
2015-11-25 |
Medizinische Universität Wien |
Personalized therapy of inflammation-associated cancer using methods of assessing the susceptibility of a subject to the treatment with EGFR inhibitors/antagonists
|
RU2694063C2
(ru)
|
2014-07-08 |
2019-07-09 |
Эмфастар Фармасьютикалз, Инк. |
Тонкодисперсный инсулин, тонкодисперсные аналоги инсулина и способы их промышленного получения
|
EP3185932A1
(en)
|
2014-08-06 |
2017-07-05 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
US10575417B2
(en)
|
2014-09-08 |
2020-02-25 |
The Stanley Works Israel Ltd. |
Jobsite communications center
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US11083788B2
(en)
|
2014-10-10 |
2021-08-10 |
The Regents Of The University Of Michigan |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
AU2015338717B2
(en)
|
2014-10-31 |
2018-12-20 |
Glaxosmithkline Intellectual Property Development Limited |
Powder formulation
|
EP3616689A1
(en)
|
2014-11-24 |
2020-03-04 |
Entrinsic Health Solutions, Inc. |
Amino acid compositions for the treatment of symptoms of disease
|
US11225648B2
(en)
|
2015-01-04 |
2022-01-18 |
Protalix Ltd. |
Modified DNase and uses thereof
|
WO2016135139A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
2,3-dihydrocyclopenta[b]quinoline derivatives as mth1 inhibitors for the therapy of cancer
|
WO2016135137A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Substituted 4-(phenylamino)quinoline derivatives as mth1 inhibitors for the therapy of cancer
|
WO2016135138A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer
|
WO2016135140A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
4-aminoquinazoline derivatives as mth1 inhibitors for the therapy of cancer
|
EP3285753A1
(en)
|
2015-04-22 |
2018-02-28 |
CeMM - Forschungszentrum für Molekulare Medizin GmbH |
Combination of an antiandrogen with a vitamin k antagonist or with a gamma -glutamyl carboxylase inhibitor for the therapy of androgen receptor positive cancer
|
CN108295346A
(zh)
*
|
2015-05-16 |
2018-07-20 |
苏州汉方医药有限公司 |
一种药物器械组合成的用于治疗癌症的药盒
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
WO2016196976A1
(en)
|
2015-06-04 |
2016-12-08 |
Xeris Pharmaceuticals, Inc. |
Glucagon delivery apparatuses and related methods
|
EP3307295A1
(en)
|
2015-06-10 |
2018-04-18 |
Xeris Pharmaceuticals, Inc. |
Use of low dose glucagon
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
IL259864B
(en)
|
2015-12-09 |
2022-07-01 |
Univ Wien Med |
Monomaleimide-functionalized platinum compounds for cancer therapy
|
CN106968984B
(zh)
*
|
2015-12-11 |
2020-10-23 |
松下知识产权经营株式会社 |
涡轮机
|
US10322168B2
(en)
|
2016-01-07 |
2019-06-18 |
Amphastar Pharmaceuticals, Inc. |
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
|
CA3011192A1
(en)
|
2016-01-15 |
2017-07-20 |
Universitat Hamburg |
Flavonoide-type compounds bearing an o-rhamnosyl residue
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
AU2017210319A1
(en)
|
2016-01-20 |
2018-08-23 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
GB2552856A
(en)
|
2016-02-01 |
2018-02-14 |
Incarda Therapeutics Inc |
Combining electronic monitoring with inhaled pharmacological therapy to manage atrial arrhythmias including atrial fibrillation
|
MX2018009870A
(es)
|
2016-02-15 |
2018-11-29 |
Cemm Forschungszentrum Fuer Molekulare Medizin Gmbh |
Inhibidores de taf1 para la terapia del cancer.
|
GB2555264A
(en)
|
2016-04-15 |
2018-04-25 |
Univ Oxford Innovation Ltd |
Adenosine receptor modulators for the treatment of circadian rhythm disorders
|
US10704425B2
(en)
*
|
2016-07-14 |
2020-07-07 |
General Electric Company |
Assembly for a gas turbine engine
|
MX2019003821A
(es)
|
2016-10-04 |
2019-12-18 |
Univ Florida |
Composiciones de aminoacidos y usos de las mismas.
|
AU2017359288A1
(en)
|
2016-11-14 |
2019-05-30 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Combination of a BRD4 inhibitor and an antifolate for the therapy of cancer
|
CN110869018A
(zh)
|
2017-05-10 |
2020-03-06 |
英凯达治疗公司 |
通过肺部施用治疗心脏病况的单位剂量、气雾剂、试剂盒和方法
|
JP7165146B2
(ja)
|
2017-05-22 |
2022-11-02 |
インスメッド インコーポレイテッド |
グリコペプチド誘導体化合物およびそれらの使用
|
JP7299166B2
(ja)
|
2017-06-02 |
2023-06-27 |
ゼリス ファーマシューティカルズ インコーポレイテッド |
沈殿抵抗性低分子薬物製剤
|
JP7338873B2
(ja)
|
2017-07-19 |
2023-09-05 |
ユニケリス・リミテッド |
強皮症関連血管障害を治療または改善するための組成物および方法
|
WO2019110139A1
(en)
|
2017-12-05 |
2019-06-13 |
Eth Zurich |
New compounds for use as a therapeutically active substance and in particular for use in the treatment of tumors
|
EP3768378A4
(en)
|
2018-03-22 |
2021-11-17 |
InCarda Therapeutics, Inc. |
INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE
|
AU2019247641A1
(en)
|
2018-04-06 |
2020-11-12 |
Zilentin AG |
Bumetanide derivatives for the therapy of hyperhidrosis
|
WO2019193161A1
(en)
|
2018-04-06 |
2019-10-10 |
Universität Wien |
Bumetanide derivatives for the therapy of stroke and other neurological diseases/disorders involving nkccs
|
PL3599243T3
(pl)
|
2018-07-26 |
2023-08-21 |
Cvie Therapeutics Limited |
Związki podobne do 17beta-heterocyklilu naparstnicy do leczenia niewydolności serca
|
CA3122354A1
(en)
|
2018-12-17 |
2020-06-25 |
Tolremo Therapeutics Ag |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancer
|
WO2020223237A1
(en)
|
2019-04-29 |
2020-11-05 |
Insmed Incorporated |
Dry powder compositions of treprostinil prodrugs and methods of use thereof
|
RU193395U1
(ru)
*
|
2019-06-17 |
2019-10-28 |
Евгений Викторович Крейдин |
Генератор сухого солевого аэрозоля
|
US11007185B2
(en)
|
2019-08-01 |
2021-05-18 |
Incarda Therapeutics, Inc. |
Antiarrhythmic formulation
|
WO2021064141A1
(en)
|
2019-10-02 |
2021-04-08 |
Tolremo Therapeutics Ag |
Inhibitors of dual specificity tyrosine phosphorylation regulated kinase 1b
|
US20230064948A1
(en)
|
2019-10-02 |
2023-03-02 |
Tolremo Therapeutics Ag |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer
|
FI3805243T3
(fi)
|
2019-10-09 |
2024-02-07 |
Windtree Therapeutics Inc |
Androstaanijohdannaisia, joilla on aktiivisuus puhtaina tai pääasiallisesti puhtaina SERCA2a:n stimulaattoreina, sydämen vajaatoiminnan hoitoon
|
WO2021074418A1
(en)
|
2019-10-16 |
2021-04-22 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Carbazole-type cullin ring ubiquitin ligase compounds and uses thereof
|
IL292153A
(en)
|
2019-10-16 |
2022-06-01 |
Cemm Forschungszentrum Fur Molekulare Medizin Gmbh |
Oxazole and thiazole choline ubiquitin ligase ring compounds and uses thereof
|
US20230158125A1
(en)
|
2020-04-20 |
2023-05-25 |
Sorrento Therapeutics, Inc. |
Pulmonary Administration of ACE2 Polypeptides
|
CA3184062A1
(en)
|
2020-06-25 |
2021-12-30 |
Stefanie Fluckiger-Mangual |
Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic disease
|
EP3939578A1
(en)
|
2020-07-13 |
2022-01-19 |
Novaremed Ltd. |
Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
|
EP3964497A1
(en)
|
2020-09-04 |
2022-03-09 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Substituted vicinal diamine compounds and their use in the treatment, amelioration or prevention of pain
|
IL301970A
(en)
|
2020-10-07 |
2023-06-01 |
Protalix Ltd |
A long-acting DNase
|
JP2023545588A
(ja)
|
2020-10-16 |
2023-10-30 |
ツェーエムエム-フォルシュングスツェントルム フュア モレクラレ メディツィン ゲーエムベーハー |
ヘテロ環式カリンringユビキチンリガーゼ化合物及びその使用
|
AR125312A1
(es)
|
2021-04-07 |
2023-07-05 |
Tolremo Therapeutics Ag |
Derivados heterocíclicos, composiciones farmacéuticas y su uso en el tratamiento o la mejora del cáncer
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
WO2023203172A1
(en)
|
2022-04-20 |
2023-10-26 |
Proxygen Gmbh |
Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof
|